Dr. Michael P. Flaherty’s TCT 2018 presentation on Renal Effects of Impella support during Protected PCI.
Key Takeaways In a group of patients undergoing radial access, 15.4% developed acute kidney injury (AKI) after percutaneous coronary intervention (PCI) compared with 17.4% in the femoral access group. Randomized clinical trials demonstrating the effectiveness of radial access (RA) on improved outcomes following percutaneous coronary intervention (PCI) have increased interventionalists’ utilization of RA.1,2 Despite the … Continue reading “The MATRIX Trial: AKI After Radial or Femoral Access for Invasive ACS Management”
Dr. Anand Prasad, of University of Texas Health Science Center, draws on his experience with cardiac and renal disease to share highlights from his course, Renal Considerations in Cardiogenic Shock. The goal of the meeting was to bring together cardiologists, primary care specialists, and nephrologists to address the challenges of chronic kidney disease. Watch the … Continue reading “Renal Considerations in Cardiogenic Shock”
Use of Impella® Devices During High-Risk PCI is Associated with Reduced Occurrence of Acute Kidney Injury
New Study Finds Impella® Heart Pump Reduces Injury to Kidneys During High-Risk Percutaneous Coronary Intervention
Specialist Opinion with Dr. Seth Bilazarian A new retrospective, single-center study published in Circulation Research finds use of hemodynamic support with Impella 2.5® heart pump during high-risk percutaneous coronary intervention (HRPCI) can reduce the risk of acute kidney injury (AKI) even when those patients had preexisting kidney disease and low ejection fraction (EF). The new … Continue reading “New Study Finds Impella® Heart Pump Reduces Injury to Kidneys During High-Risk Percutaneous Coronary Intervention”